stella
beta
IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study — Stella
Home
/
Crohn's Disease
/
IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
View on ClinicalTrials.gov
Recruiting
Back to Crohn's Disease trials
IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
Trial locations
(1 site)
China
The Third Xiangya Hospital of Central South University, Changsha, Hunan